Keywords: nu-lotan, driving, sales, banyu, japanese, drugmaker, -owned
Nu-lotan driving sales at Banyu
Article | 08 June 2001
Banyu, the Japanese drugmaker 51%-owned by Merck & Co, posted sales of169.75 billion yen ($1.42 billion) for the fiscal year ended March 2001, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
